Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Weed (BUDZ) Cost of Revenue (2022)

Weed has reported Cost of Revenue over the past 3 years, most recently at -$2230.0 for Q4 2022.

  • For Q4 2022, Cost of Revenue changed N/A year-over-year to -$2230.0; the TTM value through Mar 2025 reached -$2230.0, changed N/A, while the annual FY2011 figure was $12950.0, 67.78% down from the prior year.
  • Cost of Revenue for Q4 2022 was -$2230.0 at Weed, down from $2230.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $2230.0 in Q3 2022 and troughed at -$2230.0 in Q4 2022.